2 weeks Ago By ABMN Staff
Heart Test Laboratories, Inc. ( NASDAQ:HSCS – Get Free Report ) was the target of a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 104,900 shares, an increase of 164.
2% from the August 31st total of 39,700 shares. Based on an average daily volume of 364,400 shares, the short-interest ratio is presently 0.3 days.
Currently, 13.0% of the company’s shares are short sold. Analyst Upgrades and Downgrades Separately, Ascendiant Capital Markets reissued a “buy” rating and set a $15.
00 target price on shares of Heart Test Laboratories in a research note on Monday. Check Out Our Latest Stock Analysis on Heart Test Laboratories Heart Test Laboratories Trading Up 6.6 % About Heart Test Laboratories ( Get Free Report ) Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices.
The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. Recommended Stories Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.
com's FREE daily email newsletter ..
